ACTREC Navi Mumbai Anti-Cancer Compounds SRF Walk IN


TATA MEMORIAL CENTRE ADVANCED CENTRE FOR TREATMENT, 
RESEARCH ANDEDUCATION IN CANCER
Kharghar, Navi Mumbai- 410 210 

WALK - IN - INTERVIEW (ON PROJECT) 

To work on the project entitled "Understanding mechanistic role of CARAF & CAGHE as immunomodulatory and anti-cancer compounds against pre-clinical models of Leukemia, Lymphoma, Melanoma, Lung and Breast cancer

1. SENIOR RESEARCH FELLOW:- 

EDUCATIONAL QUALIFICATION: MSc in Life Sciences or equivalent with minimum 60% marks in the qualifying exam. Candidate should be CSIR-UGC NET or GATE qualified. 

Minimum Two years of research experience is essential. 

Preference will be given to those who possess higher qualification viz., or who have previous research experience i. e. having worked for any research project funded by the Ministry of AYUSH, ICMR, CSIR, DST or equivalent organization ii. Skills or drafting editing of scientific documents/articles/ technical reports etc. 

AGE LIMIT: Maximum 35 years as on 01-04-2022. 

CONSOLIDATED SALARY: Rs. 43,400/- (Rs. 35,000/-+24% HRA) p.m. 

DURATION: Six months and extendable. The work progress of candidate will be monitored and extension will be given after six months. 

2. LAB ATTENDANT:- EDUCATIONAL QUALIFICATION: 

(i) l0+2 in Science subjects (ii) Work experience of 1 years in research / laboratory techniques preferable. 

CONSOLIDATED SALARY: Rs. 18,000/-.pm AGE LIMIT: Not more than 27 years as on 01-04-2022. 

DURATION: Six months and extendable. The work progress of candidate will be monitored and extension will be given after six months. 

Eligible Candidates may attend the walk in interview on 12th May, 2022, Thursday at Seminar Room, 3 rdFloor, Khanolkar Shodhika, ACTREC along with recent CV & original and attested copies of all certificates and testimonials with recent passport size photograph. Reporting Time: 09.30 a.m. To 10.00 a.m. 

Subscribe our Twitter Channel to get all updates: Join Now!

To Get All Updates from helpBIOTECH, Subscribe Now by Email

Post a Comment

0 Comments